Abstract
The possible consequences of the event of a supersonic transport cabin decompression are discussed in terms of biomedical considerations for passengers. Recent data concerning health and age-sex distributions are reviewed in an effort to derive a model group likely to be encountered among future supersonic transport flights along both transcontinental and transatlantic routes. Further consideration is directed to an analysis of various disease groups in terms of functional impairment as a means of anticipating passenger safety during cabin decompression. The results have been used to establish a basis for safety equipment design recommendations. Finally, attention is directed to research areas and methodology by which usable statistics might be obtained to provide further clarification of the tolerance ranges of debilitated humans.
Get full access to this article
View all access options for this article.